A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.

Clinical trial NCT06561555 · RECRUITING

Trial details

NCT number: NCT06561555
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mammary or Extramammary Paget's Disease

Start date: 2024-08-15
Primary completion: 2025-08-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.